The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NASDAQ-100 Equal Weighted IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is the equal-weighted version of the NASDAQ-100 IndexÂ® which includes 100 of the largest U.S. and international non-financial companies listed on Nasdaq based on market capitalization.
Inception Date: 19/04/2006
Primary Benchmark: NASDAQ US-100 Equal Weighted TR
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 0.6%
Management Expense Ratio: 0.60 %
|BNTX||BioNTech SE||0.00 %||
|FREQ||Frequency Therapeutics, Inc||0.00 %||
|HBT||HBT Financial, Inc||0.00 %||
|OPRT||Oportun Financial Corporation||0.00 %||
|VIE||Viela Bio, Inc||0.00 %||
|VIR||Vir Biotechnology, Inc||0.00 %||
|ALFC||Alfacourse Inc||0.00 %||
|AMRQQ||Alta Mesa Resources, Inc||0.00 %||
|AMRWQ||Alta Mesa Resources, Inc||0.00 %||
|BSML||Invesco BulletShares (R) 2021 ..||0.00 %||
|Market Performance vs.
|Market Performance vs. Exchange|
|Value||Sector Median||Percentile Rank||Grade||Market Median||Percentile Rank||Grade|
|Trailing 12 Months|
|Trailing 5 Years|
|Average Annual (5 Year Horizon)|
|Risk Return Profile|
|Volatility (Standard Deviation)||11.23%||45%||F||85%||B|
|Risk Adjusted Return||98.82%||85%||B||92%||A-|
|Letter Grade||Percentage||Letter Grade||Percentage||Letter Grade||Percentage|
|Target Price Action||Rating Action||Analyst||Rating||Price||Date|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.